crenezumab

Home
Ligands
crenezumab

GtoPdb Ligand ID: 6934

Synonyms: MABT-5102A | Mabt5102A

Comment: This antibody targets amyloid β (Aβ) protein.
Annotated peptide sequences for this antibody are available in its IMGT/mAb-DB record.

Summary
Biological activity
Clinical data
References

References
1. Garber K. (2012) Genentech's Alzheimer's antibody trial to study disease prevention. Nat Biotechnol, 30 (8): 731-2. [PMID:22871696]
2. Pfeifer A, Pihlgren M, Muhs A, Watts R. (2011) Humanized anti-beta-amyloid antibody. Patent number: US7892544. Assignee: Ac Immune Sa, Genentech, Inc.. Priority date: 14/07/2006. Publication date: 22/10/2012.

References

1. Garber K. (2012)
Genentech's Alzheimer's antibody trial to study disease prevention.
Nat Biotechnol, 30 (8): 731-2. [PMID:22871696]

2. Pfeifer A, Pihlgren M, Muhs A, Watts R. (2011)
Humanized anti-beta-amyloid antibody.
Patent number: US7892544. Assignee: Ac Immune Sa, Genentech, Inc.. Priority date: 14/07/2006. Publication date: 22/10/2012.